STRS Ohio’s Praxis Precision Medicines PRAX Stock Holding History

STRS Ohio’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.44M	Buy	4,300 +700	+19%	+$222K	0.01%	609
2026 Q1	$1.16M	Buy	3,600 +400	+13%	+$124K	﹤0.01%	676
2025 Q4	$943K	Buy	+3,200	New	+$596K	﹤0.01%	720
2021 Q3	–	Sell	-180	Closed	-$49K	–	2305
2021 Q2	$49K	Hold	180	–	–	﹤0.01%	2112
2021 Q1	$88K	Hold	180	–	–	﹤0.01%	1966
2020 Q4	$148K	Buy	+180	New	+$105K	﹤0.01%	1810

Other funds holding PRAX

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

STRS Ohio's PRAX Position: Q2 2026 in Review

STRS Ohio increased its Praxis Precision Medicines (PRAX) stake by 19% in Q2 2026, buying an estimated $222K and bringing the position to 4,300 shares worth $1.44M. The position accounts for 0.01% of the portfolio, ranked #609.

STRS Ohio first reported a position in PRAX in Q4 2020 and has held it in 6 quarters since. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

STRS Ohio held 4,300 shares of Praxis Precision Medicines worth $1.44M as of Q2 2026.
STRS Ohio bought 700 Praxis Precision Medicines shares in Q2 2026, an estimated $222K.
Praxis Precision Medicines made up 0.01% of STRS Ohio's portfolio in Q2 2026, its #609 holding.
STRS Ohio first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 6 quarters since.
310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.